I want to donate

Internal Medicine is the main medical discipline in the care of adults with one or several complex acute or chronic diseases. The main areas of action are the complex chronic patient, acute patient, medical and surgical unit support, management of multi-organ diseases and the diagnosis and management of poorly defined syndromic pictures and minority diseases. Our Internal Medicine Service manages 1300 annual discharges, 1100 hospital interconsultations and 800 first visits to outpatient clinics. The main DRGs are infectious diseases, cardiac insufficiency and venous thromboembolic disease, as well as systemic-autoimmune diseases due to their idiosyncrasy.

From this environment arises the type of research in which the group feels involved, basically clinical-epidemiological to better understand the risk factors, diagnosis, treatment and prognosis of the pathologies that we assist.

Currently the staff is made up of 14 doctors with a post and 7 resident doctors. Most of them are interested and involved in research.

Main lines of research
  • Venous thromboembolic disease
  • Infectious Diseases: COVID-19, AIDS, MTS, Tuberculosis, ARI/Pneumonia.
  • Cardiac insufficiency
  • Autoimmune-systemic diseases.
Strategic objectives
  • Clinical-epidemiological research
  • Participation in National Registries
  • Participation in Phase II-III Clinical Trials
  • Development of Doctoral Theses

Persons with SARS-CoV-2 during the First and Second Waves in Catalonia (Spain): A Retrospective Observational Study Using Daily Updated Data.

JMIR Public Health and Surveillance, 2022, 8

Álvarez Bravo G, Sánchez Cirera L, Angerri Nadal M, Ramió I Torrentà L

Clinical heterogeneity in patients with myoclonus associated to COVID-19.

NEUROLOGICAL SCIENCES, 2022, 43, 1587-1592

González-Franco Á, Cerqueiro González JM, Arévalo-Lorido JC, Álvarez-Rocha P, Carrascosa-García S, Armengou A, Guzmán-García M, Trullàs JC, Montero-Pérez-Barquero M, Manzano L, RICA registry investigators

Morbidity and mortality in elderly patients with heart failure managed with a comprehensive care model vs. usual care: The UMIPIC program.

Revista Clinica Espanola, 2022, 222, 123-130

Post-COVID-19 patients show an increased endothelial progenitor cell production.

Translational Research : The Journal Of Laboratory And Clinical Medicine, 2022, 243, 14-20

Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain.

Global Epidemiology, 2022, 4, 100071-100071

Giorgi-Pierfranceschi M, Monreal M, Di Micco P, Francisco I, Hernández-Blasco L, Madridano O, López-Sáez JB, Hernando E, Meireles J, Dentali F, The Riete Investigators

Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data.

Medicina-Lithuania, 2022, 58

Fanlo P, Espinosa G, Adan A, Fonollosa A, Segura A

Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group.

REVISTA CLINICA ESPANOLA, 2021, 221, 221-225

Mayneris-Perxachs J, Russo MF, Ramos R, de Hollanda A, Arxé AA, Rottoli M, Arnoriaga-Rodríguez M, Comas-Cufí M, Bartoletti M, Verrastro O, Gudiol C, Fages E, Giménez M, Gil AG, Bernante P, Tinahones F, Carratalà J, Pagotto U, Hernández-Aguado I, Fernández-Aranda F, Meira F, Castro Guardiola A, Mingrone G, Fernández-Real JM, Obesity-T2DM Covid19 Study Group

Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain.

Frontiers in Endocrinology, 2021, 12, 741248-741248

Dubois-Silva Á, Barbagelata-López C, Piñeiro-Parga P, Francisco I, Falgá C, Tirado R, Suriñach JM, Vela JR, Mella C, Quere I, Siniscalchi C, Monreal M, RIETE Investigators

Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs.

THROMBOSIS AND HAEMOSTASIS, 2021, 121, 1650-1659

Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.

Competitive projects
Codi oficial: 101046118 Start date:01/12/2021 Data fi: 31/05/2024 Investigador/a principal: ANTONI CASTRO GUARDIOLA Organisme finançador: EUROPEAN COMISSION Ajuda: 378,125 €
Job offers


If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in